Cytosorbents Corporation (CTSO) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Lamadrid David mit 7,837,500 Aktien. Weitere bedeutende Anteilseigner sind Chan Phillip P. und BERGER RONALD.
In den letzten 12 Monaten haben Insider 9 Transaktionen in CTSO Aktien getätigt — 9 Käufe (im Wert von $606.5K) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
CTSO Insider-Beteiligungen
Größter Aktionär
Lamadrid David
7,837,500 Aktien
Käufe (12 Monate)
9
$606.5K Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Lamadrid David |
Chief Financial Officer |
7,837,500 |
2011-09-09 |
|
| 2 |
Chan Phillip P. |
Chief Executive Officer |
1,482,963 |
2025-11-20 |
|
| 3 |
Berger Ronald |
Interim CFO |
873,000 |
2013-07-17 |
|
| 4 |
Chassman Margie |
10 Percent Owner |
400,000 |
2006-11-17 |
|
| 5 |
Winchester James F |
Chief Medical Officer |
356,250 |
2008-06-27 |
|
| 6 |
Shipley Robert |
10 Percent Owner |
199,760 |
2015-01-23 |
|
| 7 |
Rubin Joseph |
Director |
150,000 |
2014-07-24 |
|
| 8 |
Capponi Vincent |
President and COO |
111,100 |
2025-08-08 |
|
| 9 |
Deliargyris Efthymios |
Chief Medical Officer |
95,000 |
2025-08-08 |
|
| 10 |
Mariani Peter J |
Chief Financial Officer |
90,000 |
2025-08-08 |
|
| 11 |
Bloch Kathleen P. |
Chief Financial Officer |
87,000 |
2024-04-04 |
|
| 12 |
Katz Kurt |
Director |
45,000 |
2008-06-27 |
|
| 13 |
Bator Michael G. |
Director |
44,000 |
2025-08-08 |
|
| 14 |
Kraus Al |
Director |
37,950 |
2022-08-12 |
|
| 15 |
Mortensen Eric R. |
Chief Medical Officer |
35,000 |
2019-08-16 |
|
| 16 |
Miller William R |
Director |
25,000 |
2008-06-27 |
|
| 17 |
Sobel Alan D. |
Director |
22,000 |
2025-08-08 |
|
| 18 |
Jones Edward Raymond |
Director |
22,000 |
2025-08-08 |
|
| 19 |
Kim Jiny |
Director |
22,000 |
2025-08-08 |
|
| 20 |
Bartlett Robert Hawes |
Chief Medical Officer |
20,000 |
2017-02-28 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2025-11-18 |
Chan Phillip P. |
Chief Executive Officer |
RSU-Zuteilung |
100,000 |
$0.64 |
$64K |
| 2025-08-08 |
Kim Jiny |
Director |
RSU-Zuteilung |
22,000 |
$1.00 |
$22K |
| 2025-08-08 |
Deliargyris Efthymios |
Chief Medical Officer |
RSU-Zuteilung |
95,000 |
$1.00 |
$95K |
| 2025-08-08 |
Bator Michael G. |
Director |
RSU-Zuteilung |
44,000 |
$1.00 |
$44K |
| 2025-08-08 |
Sobel Alan D. |
Director |
RSU-Zuteilung |
22,000 |
$1.00 |
$22K |
| 2025-08-08 |
Chan Phillip P. |
Chief Executive Officer |
RSU-Zuteilung |
136,400 |
$1.00 |
$136.4K |
| 2025-08-08 |
Jones Edward Raymond |
Director |
RSU-Zuteilung |
22,000 |
$1.00 |
$22K |
| 2025-08-08 |
Capponi Vincent |
President and COO |
RSU-Zuteilung |
111,100 |
$1.00 |
$111.1K |
| 2025-08-08 |
Mariani Peter J |
Chief Financial Officer |
RSU-Zuteilung |
90,000 |
$1.00 |
$90K |
